Pathology & Cancer Epidemiology Summit 2018: Call for Papers | CME | CPD

“Pathology:Current trends, Advancements and Emerging Challenges”

The Conference

Pathology 2018 is designed for practitioners in Pathology research, insight and strategy who play a vital role in enabling brands to understand their customers. The conference provides a platform for innovative, disruptive and passionate leaders in the marketing insight industry pioneering new ways of deriving actionable insight.

We are putting out call for proposals, keynotes, case-studies and topics for panel discussions and debates that will form the agenda for 2018 Summit. We welcome anyone who has a compelling story to tell, creative and collaborative project to showcase or present game-changing future.

Conference Theme

The over-arching theme for Pathology 2018 is once again “Pathology: Current trends, Advancements and Emerging Challenges”.

Who Can Submit?

Market Research Summit is a diverse conference and would very much welcome anyone involved in the new era of insight. This conference is designed to showcase the talents of a wide range of professionals. It is a forum for various ideas, innovation, passion and forward-looking opinion.

In building a conference that examines the face of modern research, insight and understanding Medical and Clinical, Pathology2018 would welcome participants in the following roles and beyond:

• Insight Director
• Marketing Director
• Head of Market Research
• Ad Planner
• Data Scientist
• Brand Strategist
• Digital Marketer
• Product Designer
• Futurologist
• Economist
• Data Analyst
• Customer Experience Director

If you want to challenge, disrupt and inspire, we’d like to hear from you.

How to Submit?

Please click the below link and go through the steps in the online form to submit your proposal.

Guidelines

If you are including any clients/brands to your proposal ensure that they are fully signed up to the idea of appearing at the conference. We will not accept names that are tentative, even at this early stage. Please ensure that any permission required for the materials presented at conference are confirmed by the contributor.

Stage presence

First-timers are most welcome but please ensure that the proposed speaker has strong public speaking experience. Speakers who can prove a stage presence and ability to tell their story compellingly will be given preference.

Original material

If your paper has been presented elsewhere at an UK/EU event, it is very likely that the proposal will not be accepted. Priority will be given to original material only.

Multiple Submissions

We welcome multiple submissions from organizations and individuals as there are no restrictions on the number of proposals you can submit.

Sales pitches

Any submission resembling a sales pitch, or heavily reliant on trademarked products and services will be rejected. Such proposals will have to be put forward via sponsored opportunities.

Inflexibility

If you or your organisation is severely restricted in what it can or cannot say about a submitted proposal, please do not apply.

The Abstract submissions Open.

Please email your queries to the support team at pathology@eurosciconconferences.com or call (+44) 020 3807 3712

Pathology News

Articles for Doctors and Specialists

Thousands of medical professionals rely on HealthDay's Physician's Briefing for the most timely, relevant and accurate pathology news.  Our daily pathology news feed is designed especially for doctors and specialists who want in-depth, objective, evidence-based pathology articles that summarize the top medical journals and the latest research. Our articles for pathologists are written by our award-winning editorial team, led by Dr. Cindy Haines, HealthDay's Chief Medical Officer.
 
Topics covered in our pathology news feed include:

•   Anatomic pathology
•   Clinical pathology
•   Molecular pathology
•   Psychopathology
•   Surgical pathology
•   Hematopathology
•   Compliance
•   Best practices
•   Genetics
•   Pharmacology
•   FDA actions

…and much more
Our pathology news service also includes conference highlights and abstracts.
Conference coverage includes:

•   International Conference on Alzheimer's Disease
•   American College of Physicians
•   American Association for Cancer Research
•   American Academy of Neurology
•   American Academy of Dermatology
•   American Society of Clinical Oncology

Put Our Pathology Articles to Work For Your Organization

Stay ahead of the latest in pathology news with Physician's Briefing, the timesaving, turnkey resource for pathologists.  As part of your Physician's Briefing license you'll receive pathology articles Monday through Friday.


Join the thousands of physicians worldwide who depend on Physician's Briefing for professional medical news. 

Pathology News and Research | Pathology Conferences

Pathology is the study and diagnosis of disease through examination of organs, tissues, bodily fluids, and whole bodies (autopsies). The term also encompasses the related scientific study of disease processes, called General pathology. Medical pathology is divided in two main branches, Anatomical pathology and Clinical pathology. Veterinary pathology is concerned with animal disease whereas Phytopathology is the study of plant diseases.

Further Reading

• Pathology - What is Pathology?
• Types of Pathology
• Advances in Digital Pathology

Scientists use artificial intelligence to create new ‘ImmunoMap’

Johns Hopkins scientists have used a form of artificial intelligence to create a map that compares types of cellular receptors, the chemical "antennas" on the surface of immune system T-cells.

8 Jan 2018

Targeted fluorescence successfully identifies pulmonary metastases in osteosarcoma patient

In a proof-of-principle case report, researchers announce that targeted fluorescence successfully identified pulmonary metastases in a patient with osteosarcoma, making it easier for surgeons to locate the tumors for resection.

5 Jan 2018

Adrenomedullin could serve as biomarker, therapeutic target in disorders caused by leaky blood vessels

Disorders caused by a leaky vasculature are more common than most people think. Despite ICU treatment, one third of the 27 million patients globally that suffer from sepsis, and up to 20% of the more than 5 million US patients with congestive heart failure die every year from their condition.

5 Jan 2018

Newly identified germline variations increase risk of relapse or second cancers in leukemia patients

Newly identified germline variations in a key tumor suppressor gene predispose individuals to develop leukemia as children and leave them with a 1-in-4 chance of developing a second cancer later. St. Jude Children's Research Hospital scientists led the study, which appears today in the Journal of Clinical Oncology.

5 Jan 2018

Study provides insight into how early-stage breast cancer progresses to invasive ductal carcinoma

A new genetic-based model may explain how a common form of early-stage breast cancer known as ductal carcinoma in situ progresses to a more invasive form of cancer say researchers at The University of Texas MD Anderson Cancer Center.

4 Jan 2018

TriNetX reveals Natural Language Processing to Better Identify Patients for Clinical Trials

TriNetX, the global health research network for healthcare organizations, biopharmaceutical companies, and Contract Research Organizations (CROs), today announced the general availability of its Natural Language Processing (NLP) service.

3 Jan 2018

Japanese researchers propose new diagnostic criteria and treatment guidelines for thyroid storm

With a mortality rate estimated at 10%, the life-threatening condition known as thyroid storm (TS) demands rapid diagnosis and treatment and can benefit from new evidence-based guidelines for TS developed by researchers in Japan.

2 Jan 2018

Blueberry extract can enhance effectiveness of cervical cancer treatment

According to the Centers for Disease Control and Prevention, approximately 12,000 women in the United States are diagnosed with cervical cancer each year.

29 Dec 2017

Selenium protects specialized neurons from cell death during postnatal development

Exactly 200 years ago, the Swedish scientist Jöns Jacob Berzelius discovered the trace element selenium, which he named after the goddess of the moon, Selene.

29 Dec 2017

Leica Biosystems agrees with the UK Office of Life Sciences to advance AI in pathology

A transformative sector deal was announced between companies of the UK life sciences sector and the UK government on Wednesday, December 6th, 2017. This agreement draws substantial investment into the sector including the development of a trail-blazing digital pathology program leveraging Artificial Intelligence.

22 Dec 2017

Findings provide better understanding of thyroid hormones' role in mammalian seasonal changes

Researchers now have a better understanding of the role that thyroid hormones, the tissues that produce them, and the biochemical pathways on which they act have in driving seasonal reproduction in some mammals, and how this new information may help explain seasonal changes in metabolism and mood that affect humans.

21 Dec 2017

Ludwig study elucidates mechanism behind metabolic vulnerability of some breast tumors

Scientists have known since the 1980s that many cancer cells are relatively sensitive to the deprivation of an essential amino acid known as methionine. It has, however, long been unclear what causes such marked dependency on methionine.

20 Dec 2017

New findings may lead to sensitive, non-invasive test for Alzheimer's disease

New research has drawn a link between changes in the brain's anatomy and biomarkers that are known to appear at the earliest stages of Alzheimer's disease (AD), findings that could one day provide a sensitive but non-invasive test for AD before cognitive symptoms appear.

19 Dec 2017

Study links mild obsessive-compulsive symptoms to alterations of cerebral anatomy in healthy children

A new study carried out by the Bellvitge Biomedical Research Institute and the Institute of Global Health of Barcelona, a centre supported by "la Caixa" Foundation, associates for the first time mild obsessive-compulsive symptoms, which are present in a much higher percentage of cases than those that require specialized medical and psychological attention, to characteristics and specific alterations of the cerebral anatomy.

19 Dec 2017

Study suggests new treatment option for most lethal form of breast cancer

The most lethal form of breast cancer could have a new treatment option, according to new research out of the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine.

18 Dec 2017

‘Sushi-like’ nanodiscs provide structural snapshots of misfolding proteins

When proteins misfold, accumulate and clump around insulin-producing cells in the pancreas, they kill cells. Now, researchers, including University of Michigan biophysicists, have obtained a structural snapshot of these proteins when they are most toxic, detailing them down to the atomic level.

15 Dec 2017

Scientists use AI-enhanced microscope system to quickly, accurately identify bacteria

Microscopes enhanced with artificial intelligence could help clinical microbiologists diagnose potentially deadly blood infections and improve patients' odds of survival, according to microbiologists at Beth Israel Deaconess Medical Center

15 Dec 2017

Researchers uncover THOR gene involved in cancer development

It turns out Thor, the Norse god of thunder and the Marvel superhero, has special powers when it comes to cancer too.

15 Dec 2017

Study tests accuracy of laboratory-developed cancer tests and FDA-approved companion diagnostics

Cancer molecular testing can drive clinical decision making and help a clinician determine if a patient is a good candidate for a targeted therapeutic drug.

14 Dec 2017

Researchers win NIH grants for Alzheimer's research on Amish resilience and rapid onset

Researchers from Case Western Reserve University School of Medicine have received two grant awards, in partnership with investigators from other institutions, from the National Institutes of Health to conduct major studies on Alzheimer's disease, the most common form of memory loss and other forms of dementia in older persons.

Pathology & Cancer Epidemiology: Current trends, Advancements and Emerging Challenges

 17^th International Conference on

Pathology & Cancer Epidemiology

October 08-09, 2018 | Edinburgh, Scotland

Pathology Market Overview

Pathology is the causal study of the diseases by examining the body tissues sample (e.g. biopsies/pap smears) and body fluids (e.g. blood/urine etc.). It creates a bridge between the health science and medicine. Pathology cover every aspect of the patients care, starting from diagnostics to treatment advices and prevention. In general, Pathologists work with physicians, scientists, nurses and healthcare professionals in hospitals and GPs’ surgeries to diagnose, prevent and treat illness. The whole segments of pathology comprise of more than 20 different disciplines starting from general disciplines like cytopathology, histopathology, chemical pathology, hematopathology, anatomical pathology, medical microbiology to more advanced digital pathology.

The global Digital Pathology market worth about $1.98bn in 2012 and is expected to hit $5.7 billion by 2020. Automation of the conventional pathology methods is the major driving force for this market, which leads to the improvements in workflow efficiency, efficiency in analysis. The other driving factor include fast and accuracy in results, availability of diagnostics facilities in the remote areas, cost reductions, reduction in procedural cost starting from delivery of slide to data. The major drawback is the strict regulatory approval process for the digital pathology systems. The other limiting factors are: digital pathology system integration cost, and standardization of technology and data interpretation format among countries. The Whole slide imaging (WSI) is the highest revenue generating segment in this arena with the highest growth potential.

It is estimated that the Europe Digital Pathology Market to hit $151m by 2021 from $62.3m in 2012. During the same period, the USA Digital Pathology Market will reach $205.67mn from $77.23mn at a CAGR of 17%. Among all the countries, North America will dominate the Digital Pathology market followed by Europe, Latin America and Asia Pacific. Asia Pacific will witness the fastest growth (at a CAGR of 13.4%) during the forecast period. Growth will be supported by the increased number of cancer patients, increased demand of novel patient care facilities and reduced laboratory expenses.

    

Anatomic Pathology plays a key role towards the study, diagnosis and treatment of various chronic diseases such as infectious diseases and Cancer. It includes the analysis of biopsy or body parts to diagnose a disease. It is also very important in Pharmaceutical Industries to perform toxicological studies. This Anatomic Pathology market has a huge growth potential fueled by the increased prevalence of chronic diseases, increased aging population and moreover increased health care expenditures across the globe. The global Anatomic pathology market can be segmented into products type and service. The Pathology service market can be segmented into reagents, consumables, instruments, and services. The instruments can be segmented into slide strainers, tissue processers, microtomes, and application market can be segmented to drug discovery, diagnosis. Products in terms of users’ ca be segmented into Diagnostic Laboratories, hospitals, and Research organizations.

The Anatomic Pathology market is dominated by the North America, followed by Europe, and Asia. These growth is attributed to the rapid increase in chronic disease prevalence, increasing aging population, growing demand of personalized medicine, presence of big market and huge investment of both government and private bodies. The Anatomic Market valued about $16.2bn in 2016 with the potential to reach to $21.9bn by 2021 at a CAGR of 6.1%.

Global Anatomic Pathology Market Value ($bn), 2016-2021

 

In the United Kingdom (UK) there are 570 Laboratories with Clinical Pathology Accreditation, of which 123 are in London and 35 are in Scotland only (As of August 30, 2017).

The purpose of this letter is to invite you for 17th International Conference on Pathology & Cancer Epidemiology which is going to be held during Oct 08-09, 2018 at Edinburgh, Scotland around the Theme: "Pathology: Current trends, Advancements, and Emerging Challenges". The scientific-program will be a rich mix of formats ranging from keynote sessions featuring many well-known and thought-provoking speakers to intense and highly interactive discussion sessions

For more information you can have a look at Pathology Conferences

Conference highlights: • Opportunity to attend the presentations delivered by Eminent Scientists from all over     the world • Best poster presentations and Young scientist awards • Participation in sessions on specific topics on which the conference is expected to achieve progress • Global networking: In transferring and exchanging Ideas • Conference brings together Scientific Researchers & Business Entrepreneurs and Issues in Pathology

To download the brochure follows the link: Pathology Conferences

Please let me know if you will be able to attend. Awaiting your early response.

EuroSciCon Ltd            40 Bloomsbury Way Lower Ground Floor London, United Kingdom      WC1A 2SE        E: pathology@eurosciconconferences.com